Sophiris Bio, Inc. reported unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2015. The company reported a net loss of $2.5 million or $0.15 per basic and diluted share for the three months ended December 31, 2015 compared to a net loss of $5.3 million or $0.31 per basic and diluted share for the three months ended December 31, 2014.

The company reported a net loss of $14.2 million or $0.84 per basic and diluted share for the year ended December 31, 2015 compared to a net loss of $30.7 million or $1.85 per basic and diluted share for the year ended December 31, 2014.